Products of genome editing as the most promising “New Plant Breeding Technology” (NPBT) have made the transition from the lab to the market in a short time. Globally, research activities employing genome editing are constantly expanding and more and more plants with market-oriented traits are being developed, and companies have already released the first genome edited crops to the market. Few countries, most of which are located in the Americas, have adapted legislations to these technologies or released guidelines supporting the use of genome editing. Other countries are debating the path to come either because there is no clarity on the legal classification or due consensus is hampered by a renewed GMO debate. In recent years (2017−2020), eight countries have introduced guidelines clarifying the legal status of genome edited products and many of those are actively committed to international harmonization of their policies. In this publication we give an overview on the current and potentially future international regulatory environment and an update on plants derived by genome editing with market-oriented traits.

基因组编辑产品作为最有前景的“新型植物育种技术”（NPBT），已在短时间内从实验室走向市场。在全球范围内，利用基因组编辑的研究活动不断扩大，越来越多具有市场导向性状的植物正在开发中，一些公司已经向市场推出了第一批基因组编辑作物。很少有国家（其中大多数位于美洲）针对这些技术制定了立法或发布了支持使用基因组编辑的指南。其他国家正在争论未来的道路，要么是因为法律分类不明确，要么是因为新的转基因生物辩论阻碍了应有的共识。近年来（2017−2020 年），八个国家出台了明确基因组编辑产品法律地位的指南，其中许多国家积极致力于其政策的国际协调。在本出版物中，我们概述了当前和未来潜在的国际监管环境，以及通过基因组编辑衍生的具有市场导向性状的植物的最新情况。